how to break a plateau on semaglutide GLP-1 Plateaus: Why They Happen and Push Through What to Do If You

This can cause issues in patients who already have hypertension, especially if uncontrolled

To keep you safe, always communicate with your healthcare provider before changing your injection schedule

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): A 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial

March 13, 2026: FDA Sends Warning Letter to Novo Nordisk The FDA has sent a warning letter to the maker of Ozempic and Wegovy over a potential failure to report side effects connected to these drugs